6.56

3.81% -0.26

Scilex Holding Company (SCLX)

Overview News Price History Option Chain Financials Why SCLX Down? Discussions Forecast

Scilex Holding Company stock is traded at $6.56, with a volume of 100.55K. It is down -3.81% in the last 24 hours and down -15.90% over the past month. Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Previous Close:

$6.82

Open:

$6.91

24h Volume:

100.55K

Relative Volume:

0.75

Market Cap:

$46.14M

Revenue:

$33.86M

Net Income/Loss:

$-437.38M

P/E Ratio:

-0.1617

EPS:

-40.5773

Net Cash Flow:

$-42.07M

1W Performance:

-6.69%

1M Performance:

-15.90%

6M Performance:

-24.51%

1Y Performance:

-58.87%

1-Day Range:

$6.55

$7.15

1-Week Range:

$6.55

$7.43

52-Week Range:

$4.20

$34.27

Scilex Holding Company Stock (SCLX) Company Profile

Name

Scilex Holding Company

Sector

Healthcare (1074)

Industry

Drug Manufacturers - General (20)

Phone

(650) 516-4310

Address

960 SAN ANTONIO ROAD, PALO ALTO

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

SCLX's Discussions on Twitter

Compare SCLX vs LLY, JNJ, ABBV, MRK, NVS

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SCLX Scilex Holding Company	6.56	49.44M	33.86M	-437.38M	-42.07M	-40.58
LLY Lilly Eli Co	1,210.02	1.07T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	265.53	640.91B	97.93B	21.04B	17.80B	8.6278
ABBV Abbvie Inc	263.30	453.91B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	130.36	322.95B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	158.83	296.72B	54.66B	13.58B	16.05B	7.0171

Scilex Holding Company Stock (SCLX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-27-25	Initiated	D. Boral Capital	Buy
Oct-16-24	Initiated	Alliance Global Partners	Buy
Jun-13-24	Initiated	Rodman & Renshaw	Buy
Oct-16-23	Initiated	B. Riley Securities	Buy
Oct-13-23	Initiated	B. Riley Securities	Buy
Oct-09-23	Initiated	H.C. Wainwright	Buy

View All

Scilex Holding Company Stock (SCLX) Latest News

Jul 28, 2026

SCLX|Scilex Holding Co|Price:7.100|Chg%:+0.260 - TradingKey

Jul 28, 2026

Jul 27, 2026

Scilex Holding Co (SCLX) Institutional Confidence - TradingKey

Jul 27, 2026

Scilex Holding Co (SCLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026

Scilex Holding Co (SCLX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026

SCLX|Scilex Holding Co|Price:6.870|Chg%:+0.030 - TradingKey

Jul 27, 2026

Jul 26, 2026

TradingKey - TradingKey

Jul 26, 2026

Scilex Holding Co (SCLX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 26, 2026

Scilex Holding Co (SCLX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 26, 2026

Scilex Holding Co (SCLX) Cash Flow - TradingKey

Jul 26, 2026

Scilex Holding Co (SCLX) Income Statement - TradingKey

Jul 26, 2026

Jul 25, 2026

Scilex Holding Co (SCLX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 25, 2026

Scilex Holding Company Revenue Breakdown – NASDAQ:SCLXW - TradingView

Jul 25, 2026

Scilex Holding Company Revenue Breakdown – DUS:D8B0 - TradingView

Jul 25, 2026

Jul 24, 2026

Scilex Holding (SCLX) Dips 3.9% as Key Support Levels Come into FocusSmart Money Flow Stocks - dars.gov.et

Jul 24, 2026

Scilex Holding Co (SCLX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026

Jul 23, 2026

Scilex Announces Strategic Sale of Vivasor Preferred Shares - The Globe and Mail

Jul 23, 2026

Scilex Holding Company Enters Material Definitive Agreement – SEC Filing and Entity Information Details - Minichart

Jul 23, 2026

Jul 22, 2026

Scilex Sells Vivasor Preferred Shares Back for $12.0 Million, Paid in Tranches Through 2027 - TradingView

Jul 22, 2026

Jul 20, 2026

Scilex Holding (SCLX) Declines 5.33% as Shares Test Key Support Near $7.59High Conviction Picks - dars.gov.et

Jul 20, 2026

Jul 15, 2026

Enterprise value to revenue forward of Scilex Holding Company – DUS:D8B0 - TradingView

Jul 15, 2026

Jul 13, 2026

Form 13D/A Scilex Holding Company For: 7 July By Investing.com - Investing.com UK

Jul 08, 2026

Form 4 Scilex Holding Co For: 7 July By Investing.com - Investing.com India

Jul 08, 2026

Jul 07, 2026

Scilex (SCLX) JV shifts 500,000 shares to Quantum Scan in swap - Stock Titan

Jul 07, 2026

Scilex (NASDAQ: SCLX) holder reports 500K transfer, 11.4% stake - Stock Titan

Jul 07, 2026

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet - AOL.com

Jul 07, 2026

Scilex Holding Warrant (SCLXW) Remains Flat Near Support – Key Levels in FocusSymmetrical Triangle - dars.gov.et

Jul 07, 2026

Semnur Pharmaceuticals signs term sheet for $100M investment By Investing.com - Investing.com Nigeria

Jul 07, 2026

Scilex secures major growth capital equity investment - The Globe and Mail

Jul 07, 2026

Semnur Pharmaceuticals, Inc. ('Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, 'Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP - The Manila Times

Jul 07, 2026

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP - marketscreener.com

Jul 07, 2026

Scilex Holding stock rises on $100M investment term sheet By Investing.com - Investing.com

Jul 07, 2026

Jul 06, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 06, 2026

Scilex Shares Jump 10% After Landing $100 Million Investment Proposal at Premium Price - finance.biggo.com

Jul 06, 2026

Scilex, Vera Therapeutics rise premarket; Strategy gains By Investing.com - Investing.com Nigeria

Jul 06, 2026

Scilex Holding Company Announces $100 Million Strategic Investment from Kazakhstan’s iHolding Group for Global Pain Management Expansion – Minichart - Minichart

Jul 06, 2026

Scilex shares jump after securing $100 million strategic investment proposal (SCLX) - MSN

Jul 06, 2026

Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens Commence Trading on the Biconomy Exchange on July 6, 2026 - The Manila Times

Jul 06, 2026